| Stage | AII | % of rev | KRO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $115M | 100.00% | $558M | 100.00% | KRO ×4.85 |
| Gross profit | $98M | 84.88% | $103M | 18.42% | AII +66.5pp |
| Operating income | $46M | 40.31% | $38M | 6.74% | AII +33.6pp |
| Pre-tax income | $46M | 40.31% | $23M | 4.10% | AII +36.2pp |
| Net income | $34M | 29.65% | $15M | 2.72% | AII +26.9pp |
| Stage | AII | KRO | Gap · A − B |
|---|---|---|---|
| Revenue | $115M100.00% | $558M100.00% | KRO ×4.85 |
| Gross profit | 84.88%$98M | 18.42%$103M | AII +66.5pp |
| Operating income | 40.31%$46M | 6.74%$38M | AII +33.6pp |
| Pre-tax income | 40.31%$46M | 4.10%$23M | AII +36.2pp |
| Net income | 29.65%$34M | 2.72%$15M | AII +26.9pp |
No shared counterparties.